placeholder image
B. A. Buckingham All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(®) 5 Automated Insulin Delivery System
    Diabetes Technology & Therapeutics. 2024
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes
    Diabetes Technology & Therapeutics. 2024
  • Consensus recommendations for the use of automated insulin delivery technologies in clinical practice
    Endocrine Reviews. 2023
  • Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial
    Diabetes Technology & Therapeutics. 2023
  • Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes
    Diabetes Technology & Therapeutics. 2023
  • Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial
    Diabetes care. 2022
  • First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes
    Diabetes Technology & Therapeutics. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes
    Diabetes care. 2021
  • Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes
    Diabetes Technology & Therapeutics. 2017
  • Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
    JAMA. 2016
  • Contact
    full name
  • B. A. Buckingham
  • Quick Info
     
    Collaboration